FORTREA HOLDINGS INC (FTRE)
US34965K1079 - Common Stock
We assign a fundamental rating of 2 out of 10 to FTRE. FTRE was compared to 55 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of FTRE have multiple concerns. FTRE has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
FTRE had positive earnings in the past year.
FTRE had a positive operating cash flow in the past year.
1.2 Ratios
With a Return On Assets value of -8.09%, FTRE perfoms like the industry average, outperforming 58.18% of the companies in the same industry.
FTRE has a Return On Equity (-19.75%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.09% | ||
| ROE | -19.75% | ||
| ROIC | N/A |
ROA(3y)2.22%
ROA(5y)N/A
ROE(3y)2.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
FTRE's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 17.17%, FTRE is not doing good in the industry: 85.45% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of FTRE has declined.
FTRE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.17% |
OM growth 3Y-10.89%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.06%
GM growth 5YN/A
2. Health
2.1 Basic Checks
FTRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FTRE has been increased compared to 1 year ago.
The debt/assets ratio for FTRE is higher compared to a year ago.
2.2 Solvency
FTRE has an Altman-Z score of 1.28. This is a bad value and indicates that FTRE is not financially healthy and even has some risk of bankruptcy.
FTRE has a Altman-Z score (1.28) which is comparable to the rest of the industry.
FTRE has a debt to FCF ratio of 4.97. This is a neutral value as FTRE would need 4.97 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.97, FTRE is in the better half of the industry, outperforming 70.91% of the companies in the same industry.
FTRE has a Debt/Equity ratio of 0.77. This is a neutral value indicating FTRE is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.77, FTRE is doing worse than 70.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 4.97 | ||
| Altman-Z | 1.28 |
ROIC/WACCN/A
WACC10.03%
2.3 Liquidity
FTRE has a Current Ratio of 1.19. This is a normal value and indicates that FTRE is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.19, FTRE is not doing good in the industry: 83.64% of the companies in the same industry are doing better.
FTRE has a Quick Ratio of 1.19. This is a normal value and indicates that FTRE is financially healthy and should not expect problems in meeting its short term obligations.
FTRE has a Quick ratio of 1.19. This is in the lower half of the industry: FTRE underperforms 70.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.19 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
FTRE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -101.76%.
FTRE shows a small growth in Revenue. In the last year, the Revenue has grown by 0.42%.
FTRE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.41% yearly.
EPS 1Y (TTM)-101.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-583.23%
Revenue 1Y (TTM)0.42%
Revenue growth 3Y6.41%
Revenue growth 5YN/A
Sales Q2Q%-16.47%
3.2 Future
FTRE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.96% yearly.
Based on estimates for the next years, FTRE will show a small growth in Revenue. The Revenue will grow by 3.09% on average per year.
EPS Next Y-58.76%
EPS Next 2Y-0.24%
EPS Next 3Y8.96%
EPS Next 5Y23.96%
Revenue Next Year-13.3%
Revenue Next 2Y-6.68%
Revenue Next 3Y-3.08%
Revenue Next 5Y3.09%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
FTRE is valuated quite expensively with a Price/Earnings ratio of 63.19.
Compared to the rest of the industry, the Price/Earnings ratio of FTRE indicates a somewhat cheap valuation: FTRE is cheaper than 63.64% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of FTRE to the average of the S&P500 Index (29.38), we can say FTRE is valued expensively.
Based on the Price/Forward Earnings ratio of 17.22, the valuation of FTRE can be described as rather expensive.
Based on the Price/Forward Earnings ratio, FTRE is valued cheaply inside the industry as 94.55% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.98, FTRE is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.19 | ||
| Fwd PE | 17.22 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as FTRE.
Based on the Price/Free Cash Flow ratio, FTRE is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.01 | ||
| EV/EBITDA | 75.14 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.24%
EPS Next 3Y8.96%
5. Dividend
5.1 Amount
FTRE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FORTREA HOLDINGS INC
NASDAQ:FTRE (11/11/2024, 8:00:00 PM)
Premarket: 22.75 0 (0%)22.75
-0.75 (-3.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.04B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.19 | ||
| Fwd PE | 17.22 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.09% | ||
| ROE | -19.75% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.17% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.19 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-101.76%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-58.76%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)0.42%
Revenue growth 3Y6.41%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y